or Try an Advanced Search...

    Technical Analysis for HOOK - HOOKIPA Pharma Inc.

    Grade Last Price % Change Price Change
    C 0.82 0.56% 0.00
    HOOK closed up 0.54 percent on Friday, May 17, 2024, on 34 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical HOOK trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.56%
    NR7 Range Contraction 0.56%
    Fell Below 20 DMA Bearish 1.11%
    Wide Bands Range Expansion 1.11%
    Gapped Down Weakness 1.11%
    Crossed Above 20 DMA Bullish -4.54%
    Wide Bands Range Expansion -4.54%
    Gapped Down Weakness -4.54%
    20 DMA Resistance Bearish -0.58%
    Crossed Above 50 DMA Bullish -0.58%
    Older End-of-Day Signals for HOOK ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High 39 minutes ago
    20 DMA Resistance 39 minutes ago
    Up 3% 39 minutes ago
    Gap Up Partially Closed 44 minutes ago
    Rose Above 20 DMA 44 minutes ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    HOOK Chart by TradingView
    Basic chart:

    Profile

    HOOKIPA Pharma Inc. Description

    HOOKIPA Pharma Inc., a clinical-stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase 2 clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in preclinical studies for the treatment of human papillomavirus-positive cancers. The company has a collaboration with Gilead Sciences, Inc. to develop arenavirus based therapeutics to treat hepatitis B virus and human immunodeficiency virus infections. HOOKIPA Pharma Inc. was founded in 2011 and is headquartered in New York, New York.

    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Infectious Diseases Hepatitis B Transplantation Immunodeficiency Hepatitis B Virus Viral Disease Papillomavirus Gilead Sciences Immunotherapeutics Kidney Transplant

    Is HOOK a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 11 HOOKIPA Pharma First Quarter 2024 Earnings: Beats Expectations
    May 9 HOOKIPA Pharma GAAP EPS of $0.11
    May 9 HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
    Apr 26 Breaking Down HOOKIPA Pharma: 4 Analysts Share Their Views
    Apr 25 HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab
    Apr 24 Hookipa to receive $10M from Roche as FDA clears cancer trial
    Apr 24 Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday?
    Apr 24 HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers
    Apr 22 Hookipa Pharma: 04/25/24 Update Should Be The First Of Several Positive Catalysts
    Apr 16 HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
    See more HOOK news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.56
    52 Week Low 0.41
    Average Volume 825,821
    200-Day Moving Average 0.67
    50-Day Moving Average 0.79
    20-Day Moving Average 0.84
    10-Day Moving Average 0.82
    Average True Range 0.07
    RSI (14) 49.49
    ADX 19.56
    +DI 21.59
    -DI 16.70
    Chandelier Exit (Long, 3 ATRs) 0.82
    Chandelier Exit (Short, 3 ATRs) 0.91
    Upper Bollinger Bands 0.96
    Lower Bollinger Band 0.71
    Percent B (%b) 0.41
    BandWidth 29.26
    MACD Line 0.01
    MACD Signal Line 0.01
    MACD Histogram -0.0076
    Fundamentals Value
    Market Cap 78.73 Million
    Num Shares 96.6 Million
    EPS -0.80
    Price-to-Earnings (P/E) Ratio -1.02
    Price-to-Sales 3.25
    Price-to-Book 0.70
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.87
    Resistance 3 (R3) 0.87 0.86 0.86
    Resistance 2 (R2) 0.86 0.84 0.86 0.86
    Resistance 1 (R1) 0.84 0.83 0.85 0.83 0.86
    Pivot Point 0.82 0.82 0.82 0.82 0.82
    Support 1 (S1) 0.80 0.80 0.81 0.80 0.77
    Support 2 (S2) 0.78 0.80 0.78 0.77
    Support 3 (S3) 0.76 0.78 0.77
    Support 4 (S4) 0.76